Northern Trust’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.61M | Buy |
394,164
+14,147
| +4% | +$93.7K | ﹤0.01% | 2840 |
|
2025
Q1 | $3.48M | Buy |
380,017
+34,101
| +10% | +$312K | ﹤0.01% | 2617 |
|
2024
Q4 | $3.63M | Buy |
345,916
+23,523
| +7% | +$247K | ﹤0.01% | 2699 |
|
2024
Q3 | $3.85M | Buy |
322,393
+227,381
| +239% | +$2.72M | ﹤0.01% | 2632 |
|
2024
Q2 | $546K | Buy |
95,012
+15,947
| +20% | +$91.7K | ﹤0.01% | 3474 |
|
2024
Q1 | $411K | Sell |
79,065
-10,014
| -11% | -$52.1K | ﹤0.01% | 3627 |
|
2023
Q4 | $469K | Buy |
89,079
+11,065
| +14% | +$58.3K | ﹤0.01% | 3555 |
|
2023
Q3 | $257K | Buy |
78,014
+8,239
| +12% | +$27.2K | ﹤0.01% | 3718 |
|
2023
Q2 | $202K | Sell |
69,775
-204,022
| -75% | -$590K | ﹤0.01% | 3826 |
|
2023
Q1 | $293K | Buy |
273,797
+587
| +0.2% | +$628 | ﹤0.01% | 3677 |
|
2022
Q4 | $713K | Sell |
273,210
-1,783
| -0.6% | -$4.65K | ﹤0.01% | 3380 |
|
2022
Q3 | $1.93M | Buy |
274,993
+3,838
| +1% | +$26.9K | ﹤0.01% | 3032 |
|
2022
Q2 | $1.85M | Buy |
271,155
+24,608
| +10% | +$168K | ﹤0.01% | 3108 |
|
2022
Q1 | $3.48M | Sell |
246,547
-12,352
| -5% | -$174K | ﹤0.01% | 2794 |
|
2021
Q4 | $3.75M | Buy |
258,899
+121,887
| +89% | +$1.77M | ﹤0.01% | 2875 |
|
2021
Q3 | $1.94M | Buy |
137,012
+42,987
| +46% | +$609K | ﹤0.01% | 3305 |
|
2021
Q2 | $1.66M | Buy |
94,025
+706
| +0.8% | +$12.4K | ﹤0.01% | 3408 |
|
2021
Q1 | $1.43M | Buy |
+93,319
| New | +$1.43M | ﹤0.01% | 3429 |
|